AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) Shares Down 0.1% – Here’s Why

AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTALGet Free Report) fell 0.1% during mid-day trading on Friday . The stock traded as low as $19.93 and last traded at $20.05. 341,197 shares were traded during trading, a decline of 28% from the average session volume of 474,344 shares. The stock had previously closed at $20.08.

AGF U.S. Market Neutral Anti-Beta Fund Stock Down 0.1 %

The firm has a market capitalization of $342.86 million, a price-to-earnings ratio of 20.61 and a beta of -0.57. The company has a 50-day moving average price of $18.87 and a 200-day moving average price of $19.17.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. Creative Financial Designs Inc. ADV increased its holdings in shares of AGF U.S. Market Neutral Anti-Beta Fund by 20.0% during the fourth quarter. Creative Financial Designs Inc. ADV now owns 190,368 shares of the company’s stock valued at $3,518,000 after purchasing an additional 31,742 shares during the period. Magnolia Private Wealth LLC acquired a new position in AGF U.S. Market Neutral Anti-Beta Fund during the 4th quarter valued at about $331,000. Finally, Ethos Financial Group LLC increased its stake in AGF U.S. Market Neutral Anti-Beta Fund by 49.1% during the 4th quarter. Ethos Financial Group LLC now owns 20,225 shares of the company’s stock valued at $386,000 after buying an additional 6,663 shares during the period.

About AGF U.S. Market Neutral Anti-Beta Fund

(Get Free Report)

The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.

Featured Articles

Receive News & Ratings for AGF U.S. Market Neutral Anti-Beta Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AGF U.S. Market Neutral Anti-Beta Fund and related companies with MarketBeat.com's FREE daily email newsletter.